Julie Gerberding, Executive Vice President, Communications, Global Policy and Population Health, Merck & Co Inc. USA, in an interview tells Outlook how MSD for Mothers, a global initiative of US based pharmaceutical company Merck & Co. Inc. USA (known as MSD outside of US and Canada), is looking to scale up the program in India, a major focus area.
MSD for Mothers is a 10-year, $500 million philanthropic initiative of MSD Global to help empower women with information, choice and voice to access healthcare. Along with its partners, including the government, the NGOs, academia, professional associations and private companies, the program also seeks to help equip health providers with innovative products and platforms to offer better quality care to reduce maternal mortality rate.
Why has India not been able to achieve the millennium development goals in terms of women and health?
You have 25 million people born every year. I think it is a tall order managing with the geographical distribution and diversity of the population to be able to make any improvement fast. So it is a debate of glass half full and half empty. Surely there has been enormous progress, though not at the stated goal. But we are learning from the MSD for Mothers and all our partners that there is a great deal of alignment on what needs to be done and a lot of things to be optimistic that we are entering a new phase of maternal health improvement.
What has changed in the last two to three years that has helped India reduce maternal mortality rate (MMR deaths), though it still ranks low in global ranking?
It is difficult to say as I am still learning, having come from this roundtable of partners. One of things is that we have improve the quality of care both in the private sector and the public sector. Quality of care in all respect is probably the overarching issue. More births need to be attended, as not all babies are born with attendants present. So health workers need to be well trained to attend to the needs with more speed. Quality measures in treatment and care has improved but needs to be further speeded up.
Another area that I was really amazed at is the environment of partnership is so innovative. Like innovative financing like impact bond which are supporting not just innovation but digitization of provider training, digitization of the patient as consumer who can go on and look up health centres that are judged by the best quality of care they provide and quality providers who can compare themselves with quality care provided in other hospitals. So, digitization is making information exchange incredibly rich. This can help accelerate quality care and reach educational improvements through these digital platforms which are moving people up the ladder on their own skills capability.
How are you facing up to the challenge of ensuring proper utilization of your funds and gathering of right data on the outcomes?